---
figid: PMC12188105__MCO2-6-e70120-g001
figtitle: Glutamine signaling pathway and metabolism in cancer
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12188105
filename: MCO2-6-e70120-g001.jpg
figlink: /pmc/articles/PMC12188105/figure/F1/
number: F1
caption: Glutamine signaling pathway and metabolism in cancer. Glutamine enters cells
  through transporters and cotransporters like SLC1A5/ASCT2 and SLC7A11. It is converted
  to α‐ketoglutarate (α‐KG), enhancing mTORC1 signaling and HIF‐1α accumulation. mTORC1
  regulates ASCT2, GLS, and HIF‐1 via c‐Myc. It inhibits lysosome biogenesis and autophagy.
  Malate supports nucleotide synthesis and produces pyruvate and NADPH. Mutated Keap1
  induces GSH synthesis, ROS elimination, and NADPH synthesis. circHECTD1 targets
  miR‐1256 to modulate β‐catenin/c‐Myc signaling, activating GLS and ASCT2/SL1A5
papertitle: 'Glutamine Metabolism: Molecular Regulation, Biological Functions, and
  Diseases'
reftext: Mudasir A. Kumar, et al. MedComm (2020). 2025 Jul;6(7).
year: '2025'
doi: 10.1002/mco2.70120
journal_title: MedComm
journal_nlm_ta: MedComm (2020)
publisher_name: Wiley
keywords: cancer | circular RNAs | glutaminolysis | glutamine metabolism | long noncoding
  RNAs | therapeutic targeting
automl_pathway: 0.950033
figid_alias: PMC12188105__F1
figtype: Figure
redirect_from: /figures/PMC12188105__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12188105__MCO2-6-e70120-g001.html
  '@type': Dataset
  description: Glutamine signaling pathway and metabolism in cancer. Glutamine enters
    cells through transporters and cotransporters like SLC1A5/ASCT2 and SLC7A11. It
    is converted to α‐ketoglutarate (α‐KG), enhancing mTORC1 signaling and HIF‐1α
    accumulation. mTORC1 regulates ASCT2, GLS, and HIF‐1 via c‐Myc. It inhibits lysosome
    biogenesis and autophagy. Malate supports nucleotide synthesis and produces pyruvate
    and NADPH. Mutated Keap1 induces GSH synthesis, ROS elimination, and NADPH synthesis.
    circHECTD1 targets miR‐1256 to modulate β‐catenin/c‐Myc signaling, activating
    GLS and ASCT2/SL1A5
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SLC7A11
  - SLC1A5
  - EPAS1
  - RRAGB
  - KRAS
  - NRAS
  - GLS
  - GLS2
  - APTX
  - GOT2
  - GPT2
  - GLUD1
  - GRID1
  - IDH1
  - MTG1
  - RRAGC
  - H1-1
  - MTOR
  - RPTOR
  - TFEB
  - TP53
  - TP63
  - TP73
  - MYC
  - GABPA
  - NFE2L2
  - DECR1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - Cys
  - Glu
  - DON
  - Acivicin
  - Azaserine
  - Glutamine
  - GDP
  - EGCG
  - R162
  - Purpurin
  - AOA
  - Glutamate
  - GTP
  - Malate
  - Acetyl-CoA
  - MEI
  - Pyruvate
  - Fatty Acid
  - Lactate
  - Aspartate
  - Nucleotide
  - NUCLEUS
---
